Company Valuation: Mesa Laboratories, Inc.

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 1,337 934.1 591.9 644.8 488.5 565.9 -
Change - -30.14% -36.64% 8.93% -24.23% 15.84% -
Enterprise Value (EV) 1,506 1,084 591.9 644.8 488.5 565.9 565.9
Change - -27.99% -45.42% 8.93% -24.23% 15.84% 0%
P/E 728x 1,028x -2.32x -330x 73.1x 75.3x 47.8x
PBR 3.41x 2.38x 4.07x 4.05x 2.62x 2.73x 2.53x
PEG - -20x 0x 3.3x -0x 6.1x 0.8x
Capitalization / Revenue 7.25x 4.26x 2.74x 2.68x 1.96x 2.18x 2.08x
EV / Revenue 0x 0x 0x 0x 0x 2.18x 2.08x
EV / EBITDA 0x 0x 0x 0x 0x 8.95x 8.43x
EV / EBIT 0x 0x 0x 0x 0x 8.61x 8.04x
EV / FCF 0x 0x 0x 0x 0x 14.1x 12.8x
FCF Yield 2.6% 2.51% 7.02% 6.6% 8.1% 7.07% 7.83%
Dividend per Share 2 0.64 0.64 0.64 0.64 0.64 0.64 0.64
Rate of return 0.25% 0.37% 0.58% 0.54% 0.72% 0.62% 0.62%
EPS 2 0.35 0.17 -47.2 -0.36 1.21 1.36 2.143
Distribution rate 183% 376% -1.36% -178% 52.9% 47.1% 29.9%
Net sales 1 184.3 219.1 216.2 241 249.1 259.2 272.2
EBITDA 1 41.16 49.68 50.5 56.74 63.49 63.2 67.1
EBIT 1 37.9 45.82 50.5 51.36 58.23 65.7 70.4
Net income 1 1.871 0.93 -254.2 -1.974 6.712 7.567 12.13
Net Debt 169 150.4 - - - - -
Reference price 2 254.88 174.73 109.73 118.66 88.42 102.42 102.42
Nbr of stocks (in thousands) 5,246 5,346 5,394 5,434 5,525 5,525 -
Announcement Date 5/31/22 5/25/23 6/5/24 5/28/25 5/27/26 - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
75.31x - - 0.62% 566M
23.67x3.49x13.12x2.71% 164B
18.48x3.22x11.33x3.66% 104B
15.73x0.18x11.29x0.83% 55.67B
32.33x7.85x20.51x1.24% 52.92B
38.85x3.07x10.53x2.47% 42.96B
37.21x1.36x11.99x0.21% 32.87B
28.66x5.1x16.26x-.--% 27.07B
41.67x7.22x26.05x0.26% 24.79B
23.73x3.47x12.47x1.22% 21.02B
Average 33.56x 3.88x 14.84x 1.32% 52.55B
Weighted average by Cap. 25.93x 3.62x 13.78x 2.06%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. MLAB Stock
  4. Valuation Mesa Laboratories, Inc.